Responses
Abstracts Accepted for Publication
Scleroderma, myositis and related syndromes
AB0612 Efficacy of low dose and short-term IL-2 treatment to expand endogenous regulatory T cells in patients with mixed connective tissue disease
Compose a Response to This Article
Other responses
No responses have been published for this article.